PuSH - Publication Server of Helmholtz Zentrum München

61 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Grüner, B.M.* et al.: Modeling therapy response and spatial tissue distribution of erlotinib in pancreatic cancer. Mol. Cancer Ther. 15, 1145-1152 (2016)
2.
Kong, B.* et al.: A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling. Gut 65, 647-657 (2016)
3.
Berchtold, S.* et al.: Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Cancer Lett. 356, 721-732 (2015)
4.
Groß, C.* et al.: Model matters: Differences in orthotopic rat hepatocellular carcinoma physiology determine therapy response to sorafenib. Clin. Cancer Res. 21, 4440-4450 (2015)
5.
Hellfritsch, J.* et al.: Knockout of mitochondrial thioredoxin reductase stabilizes prolyl hydroxylase 2 and inhibits tumor growth and tumor-derived angiogenesis. Antioxid. Redox Signal. 22, 938-950 (2015)
6.
Singh, S.K.* et al.: Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity. EMBO J. 34, 517-530 (2015)
7.
Sprinzl, M.F. et al.: Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion. J. Hepatol. 62, 863-870 (2015)
8.
Weber, J.* et al.: CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice. Proc. Natl. Acad. Sci. U.S.A. 112, 13982-13987 (2015)
9.
Baumgart, S.* et al.: Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D. Cancer Discov. 4, 688-701 (2014)
10.
Friedmann Angeli, J.P.F.* et al.: Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180-1191 (2014)
11.
Jin, S. et al.: Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1. Nat. Commun. 5:3793 (2014)
12.
Slater, E.P.* et al.: MicroRNA-196a and -196b as potential biomarkers for the early detection of familial pancreatic cancer. Transl. Oncol. 7, 464-471 (2014)
13.
Trajkovic-Arsic, M.* et al.: Multimodal molecular imaging of integrin αvβ3 for in vivo detection of pancreatic cancer. J. Nucl. Med. 55, 446-451 (2014)
14.
Altomonte, J.* et al.: Antifibrotic properties of transarterial oncolytic VSV therapy for hepatocellular carcinoma in rats with thioacetamide-induced liver fibrosis. Mol. Ther. 21, 2032-2042 (2013)
15.
Hauer, K.* et al.: DKK2 mediates osteolysis, invasiveness and metastatic spread in Ewing sarcoma. Cancer Res. 73, 967-977 (2013)
16.
Kong, B.* et al.: Identification and characterization of an Aldh1a3-positive subtype of pancreatic ductal adenocarcinoma mediated by oncogenic Krasg12d/Erk-Mtor axis. Pancreas 42, 1360-1361 (2013)
17.
Kong, B.* et al.: Pancreatic progenitor expansion, mesenchymal cell proliferation and inflammation are required during early carcinogenesis. Pancreas 42, 1360 (2013)
18.
Richter, G.H.S.* et al.: G-protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1. J. Pathol. 230, 70-81 (2013)
19.
Serpi, R. et al.: Inbred wild type mouse strains have distinct spontaneous morphological phenotypes. Histol. Histopathol. 28, 79-88 (2013)
20.
Aichler, M. et al.: Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: A comparative study in transgenic mice and human tissues. J. Pathol. 226, 723-734 (2012)